It is a high-tech enterprise engaged in R & D, production and sales of minimally invasive medical devices
2020-09-01
On July 25, Qin Lei, President of Kaifeng Central Hospital, successfully implanted a xinsorb bioabsorbable stent for a patient with coronary heart disease
2020-09-02
On April 25, Weigao endocardial consumables group held a business invitation meeting on the listing of xinsorb absorbable coronary stent with the theme of "heart returning to nature, auspicious Hua'an" at Weihaiwei building.
2020-09-16
Xinsorb rapamycin eluting stent system。It is a high-tech enterprise engaged in R & D, production and sales of minimally invasive medical devices
2020-08-31
Shandong Hua'an Biotechnology Co., Ltd. was established in February 2008, registered in Laicheng Industrial Zone, Jinan City, Shandong Province
"Biodegradable coronary stents (xinsorb)" is a project independently developed by our company. The core of the project is new material research and application technology
On May 30, the launch conference of xinsorb Xinxiang absorbable coronary stent was successfully held at the 14th Oriental cardiology Conference (OCC 2020)。
China Innovation and entrepreneurship competition is a national entrepreneurship competition with the theme of & quot; scientific and technological innovation
Recently, the State Drug Administration approved the registration of "bio absorbable coronary rapamycin eluting stent system"……